Molecular therapy drives patient-centric health care paradigms (Q42418371)

30 October 2017

Molecular therapy drives patient-centric health care paradigms (English)

1 reference

patient-centered healthcare

30 October 2017

1 reference

Scott A Waldman

1

1 reference

PMCID

2946388

30 October 2017

Andre Terzic

series ordinal

2

1 reference

PMCID

2946388

30 October 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

Clinical and Translational Science

30 October 2017

1 reference

30 October 2017

3

1 reference

30 October 2017

4

1 reference

30 October 2017

170-171

1 reference

The Coalition Against Major Diseases: developing tools for an integrated drug development process for Alzheimer's and Parkinson's diseases

30 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Vaccine development in the twenty-first century: changing paradigms for elusive viruses

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Addressing the challenges of the clinical application of pharmacogenetic testing

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

The value, qualification, and regulatory use of surrogate end points in drug development

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Global challenges for clinical pharmacology in the developing world.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Clinically available pharmacogenomics tests

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Pharmacoepigenetics: its role in interindividual differences in drug response

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Data-driven methods to discover molecular determinants of serious adverse drug events

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Lazarus's gate: challenges and potential of epigenetic reprogramming of somatic cells

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Development of translational pharmacokinetic-pharmacodynamic models

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Anticipating clinical integration of pharmacogenetic treatment strategies for addiction: are primary care physicians ready?

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Drug development for emerging infections

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Predictive biomarkers in the development of oncology drugs: a therapeutic industry perspective.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Stem cells: biologics for regeneration.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Using pharmacoeconomics to value pharmacotherapy

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Economic evaluation of pharmacogenetic tests

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Clinical pharmacology in the molecular era.

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2946388

Pharmacogenetics: From Bench to Byte

16 August 2018

1 reference

12 December 2020

Therapeutic targeting: a crucible for individualized medicine

1 reference

12 December 2020

The economics of drug discovery and the ultimate valuation of pharmacotherapies in the marketplace

1 reference

12 December 2020

Pharmacoeconomics in the era of individualized medicine

1 reference

12 December 2020

Harnessing economic drivers for successful clinical implementation of pharmacogenetic testing

1 reference

12 December 2020

Delivery of Biologics in Cardiovascular Regenerative Medicine

1 reference

12 December 2020

10.1111/J.1752-8062.2010.00203.X

Identifiers

DOI

1 reference

30 October 2017

1 reference

30 October 2017

1 reference

PMCID

2946388